Advisory Committee Recommends That FDA Approve CTL019 for Treating Children with Leukemia
News
A U.S. Food and Drug Administration advisory committee has recommended that the agency approve Novartis’ CAR T-cell therapy CTL019 (tisagenlecleucel) as a treatment for children and young adults with leukemia. The Oncologic ... Read more